ARTICLE | Clinical News
MA09-hRPE cells regulatory update
July 4, 2011 7:00 AM UTC
The EMA's COMP granted Orphan Drug designation for Advanced Cell's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells to treat Stargardt's macular dystrophy (SMD). The hES...